The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Shoulders, tangent skims, and defensible integration — the long version

This is a generated summary. It shows the 5 most-liked posts from a topic of 21, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
VS
vial_slopeTL3Regular26 Oct 2025#1

Shoulders, tangent skims, and defensible integration — the long version Writing it up because I had to work it out twice and would rather nobody else did.

Posting the method first, because I know what the first three replies will otherwise be.

  • Column: C18, 4.6 x 250 mm, 5 um
  • Mobile phase: 0.1% TFA in water / 0.1% TFA in acetonitrile
  • Gradient: 12% to 57% organic over 22 minutes
  • Detection: 214 nm
  • Injection: 9 uL
  • Sample: retatrutide, reconstituted to 1.0 mg/mL, injected within an hour

The main peak integrates at 99% of total area. There is a small feature on the trailing edge that I cannot decide is a shoulder or a baseline artefact, and that is what I am actually asking about.

17 likes 9mo
SL
s.leclercTL4 Moderator4 Dec 2025#4
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Picking up the opening post: that is the part I would want checked first.

Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an impurity from the parent peak will not detect that impurity.

20 likes 8mo
CR
c.rasmussenTL2 Moderator10 Jan 2026#8

This follows post #5 rather than contradicting it.

On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a chromatogram with a trailing shoulder or a rising baseline it matters. Differences of one to two percentage points between defensible integrations are ordinary.

28 likes 7mo
VB
v.bhattacharyaTL2 Moderator19 Feb 2026#13
s.duarte, post #12: Worth separating two things that post #8 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound. Go to post

Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes across the peak. A passing peak-purity result says the spectrum is constant; it is weak evidence of homogeneity if the impurities have similar spectra.

21 likes in reply to #12 5mo
KH
ka.haddadTL2 Moderator20 Mar 2026#17
j.dahlberg, post #14: Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile phase almost always contains an ion-pairing acid, typically 0.1% TFA, which suppresses secondary interactions and sharpens peaks. Go to post

Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because different species absorb differently at different wavelengths. With the method stated, I can tell you something useful. Without it, all I can say is that there is one large peak.

29 likes in reply to #14 4mo

Read the full topic (21 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Column chemistry choices for a 40-residue peptide
Column chemistry choices for a 40-residue peptide — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will otherwise be.…
SRDWZVGLCV+39 43 1.1k 10mo
Gradient steepness and apparent purity: a worked comparison — the long version
Gradient steepness and apparent purity: a worked comparison — the long version — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I…
TNENDS 2 32k 1d
Why I ask for the gradient before I discuss the number
The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I…
GPSFCNNDHK+35 39 4.9k 20mo
Resolution and tailing factor: real acceptance criteria
Resolution and tailing factor: real acceptance criteria Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
NLPNV 2 15k 1mo
What a reversed-phase purity number actually is
The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I repeat…
NIBTDHFEF+87 101 27k 4h

Related topics — sharing the tags HPLC, system suitability, peak integration

TopicParticipantsRepliesViewsActivity
Second pass at: Two scans six weeks apart on different machines: a cautionary tale
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the…
NLPNVOLBV+1 5 34k 8mo
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with real criteria
On the subject in the title: Specificity, linearity, accuracy, precision, range, robustness — with real criteria Working notes rather than a conclusion. Posting the method first, because I know what the first…
AWHNFJCOT+93 99 1.4k 6d
DXA precision and the least significant change for lean mass — what changed since
DXA precision and the least significant change for lean mass — what changed since — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this…
SLJROF 2 56k 11mo
Washout with a one-week half-life: the arithmetic — does this still hold?
Washout with a one-week half-life: the arithmetic — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
AFANABANNN+41 45 12k 1d
Validating a method you did not develop
On the subject in the title: Validating a method you did not develop Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A VendorInvestigate…
CRSOSSSVJW+10 14 15k 3mo